Milestone Pharmaceuticals Inc.

NASDAQ:MIST

1.47 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -59.685-58.388-42.853-49.967-55.229-23.185-8.086
Depreciation & Amortization 0.5980.0890.0930.0970.0380.010.008
Deferred Income Tax -1.0360-7.269-5.53-1.63400
Stock Based Compensation 9.5349.0487.2794.9451.1910.6330.19
Change In Working Capital 1.243-3.2622.257-5.8072.8481.496-0.164
Accounts Receivables -2.638-0.730.465-0.112-0.169-0.1340.147
Inventory 00.73-0.4650.1120.16900
Accounts Payables 1.036-0.9070.637-2.0833.522.876-0.222
Other Working Capital 2.845-2.3551.62-3.724-0.672-1.380.058
Other Non Cash Items 2.9220.0447.2695.531.6340.7870.059
Operating Cash Flow -46.424-52.469-33.224-50.732-51.152-21.046-8.052
Investing Activities:
Investments In Property Plant And Equipment -0.112-0.27200-0.413-0.005-0.036
Acquisitions Net 137.24486.1240035.41300
Purchases Of Investments -137.132-85.852-15-90-35-3.029-16.032
Sales Maturities Of Investments 14229852035.02919.0320.045
Other Investing Activites -137.244-86.12470-70-35.41316.003-15.987
Investing Cash Flow 4.756-57.12470-70-0.38415.998-16.023
Financing Activities:
Debt Repayment -50000000
Common Stock Issued 0.5743.0885.05524.91785.36380.11530.722
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -2.2083.0885.05548.3070.04480.11530.722
Financing Cash Flow 47.7923.0885.05573.22485.40780.11530.722
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 6.124-106.50541.831-47.50833.87175.0676.647
Cash At End Of Period 13.767.636114.14172.31119.81885.94710.88